by Simran Chahal | Jul 22, 2026 | Events, Health
Vancouver, Canada – July 22, 2026 – Augurex Life Sciences Corp., a leader in autoimmune biomarker diagnostics, today announced the acceptance of three abstracts at the 2026 Association for Diagnostics and Laboratory Medicine 2026 Conference, being held July 26-30,...
by Simran Chahal | Jul 20, 2026 | Events, Health
Vancouver, Canada — July 20, 2026 — Augurex Life Sciences Corp., a leader in autoimmune biomarker diagnostics, today announced that its scientific abstract, “Anti-14-3-3eta Autoantibodies: A Novel Diagnostic Biomarker that Discriminates Axial...
by Simran Chahal | Jan 27, 2025 | Health, News
Vancouver, Canada – January 27, 2025 – Delays in diagnosing axial spondyloarthritis (axSpA) have been a persistent challenge, with many patients waiting 7 to 10 years for an accurate diagnosis. These delays can lead to missed opportunities for early treatment and a...
by Simran Chahal | Nov 15, 2024 | Business, Health, News
Quest to introduce lab-developed test based on Augurex 14-3-3η (eta) biomarker to U.S. physicians later this month Vancouver, Canada – November 15, 2024 – Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that it...
by Simran Chahal | Nov 13, 2024 | Business, Health, News
Augurex launches Anti-14-3-3eta Multiplex Analyte Specific Reagents (ASRs), supporting the development of a first-in-class diagnostic test for axial spondyloarthritis (axSpA) by New Day Diagnostics. The new laboratory developed test, which uses Anti-14-3-3eta...
